The determination of key genes, such as PRIM2, SYNPR, and RBSN, through pre-operative blood tests could enhance risk stratification, enable early detection of post-operative sepsis, and guide targeted interventions to improve patient outcomes. This evidence concerns the gene PRIM2 and Sepsis.